Oral Rifampin Plus Ofloxacin for Treatment of Staphylococcus-Infected Orthopedic Implants.

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.37.6.1214
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

Bioactive Glass Coatings for Orthopedic Metallic Implants

Journal of the European Ceramic Society
CompositesMaterials ChemistryCeramics
2003English

Biomaterials Used in Orthopedic Implants

Pamukkale University Journal of Engineering Sciences
2020English

Adjunctive Rifampin for the Treatment of Staphylococcus Aureus Bacteremia With Deep Infections: A Meta-Analysis

PLoS ONE
Multidisciplinary
2020English

Evaluation of the Knowledge on Cost of Orthopedic Implants Among Orthopedic Surgeons

Acta Ortopedica Brasileira
Physical TherapySports TherapyOrthopedicsSports MedicineRehabilitation
2016English

Characterization of Rifampin-Resistant Staphylococcus Aureus Nasal Carriage in Patients Receiving Rifampin-Containing Regimens for Tuberculosis

Infection and Drug Resistance
Infectious DiseasesPharmacology
2018English

Bactericidal Activity of a Single-Dose Combination of Ofloxacin Plus Minocycline, With or Without Rifampin, againstMycobacterium Leprae in Mice and in Lepromatous Patients

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1998English

Addition of Rifampin to Standard Therapy for Treatment of Native Valve Infective Endocarditis Caused by Staphylococcus Aureus

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2008English

Fabrication and Characterization of PLA-PGA Orthopedic Implants

Tissue Engineering
1995English

Pharmacokinetics of Ofloxacin in Male Volunteers Following Oral Administration

Pakistan Journal of Biological Sciences
AgronomyCrop Science
2002English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy